MAR 16, 2020 2:39 PM PDT

Cannabis Reduces ADHD Med Use in New Study

WRITTEN BY: Julia Travers

As the legalization of medical cannabis increases in the U.S. and around the globe, its effects on a variety of conditions and behaviors are under examination. In Israel, medical marijuana was first approved for cancer patients, those with chronic pain, and others in the 90s. Use has since expanded, with tens of thousands of people registered as users and Israel's Ministry of Health funding related research. The Evelyn Gruss Lipper Charitable Foundation also funds studies in this area and recently backed an exploration of how medical cannabis use affected the prescription drug intake of Israeli ADHD patients. 

In the U.S., it is estimated that about 6.1 million children have been diagnosed with ADHD to date. ADHD symptoms “start in early childhood and continue into adulthood. In some cases, ADHD is not recognized or diagnosed until the person is an adult,” according to the Mayo Clinic

The recent study focused on 53 Israeli medical cannabis patients who had an ADHD diagnosis. Most had previously gotten the cannabis licenses in relation to chronic pain or cancer treatment. Participants who used medical marijuana were found to use fewer prescription drugs or to stop taking ADHD medications altogether. 

Cannabis consumers were divided into high- and low-dose groups and 27 different combinations of cultivar varieties were trialed. “The cannabinoids most associated with reduced or eliminated ADHD medication use” included CBN, THC, THCV and CBD, Marijuana Moment reported. 

“These findings reveal that the higher-dose consumption of MC components (phyto-cannabinoids and terpenes) is associated with ADHD medication reduction… However, more studies are needed in order to fully understand if cannabis and its constituents can be used for management of ADHD,” the authors concluded. Jeffrey Y. Hergenrather, Joshua Aviram, Yelena Vysotski, Salvatore Campisi-Pinto, Gil M. Lewitus and David Meiri conducted the research. “Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients,” was published in the Rambam Maimonides Medical Journal in January 2020.

Article Sources:

Rambam Maimonides Medical Journal

Marijuana Moment

Mayo Clinic

 

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JUN 08, 2021
Cannabis Sciences
Can Smoking Weed Help You Lose Weight?
JUN 08, 2021
Can Smoking Weed Help You Lose Weight?
While cannabis is known to increase appetite in what is known as the ‘munchies’, some say they are able to l ...
JUN 10, 2021
Health & Medicine
Delta-8 THC: A Cause For Concern
JUN 10, 2021
Delta-8 THC: A Cause For Concern
Delta-8 THC is an ingredient in hemp that can get you high like THC but is currently federally legal due to a loophole i ...
JUL 08, 2021
Cannabis Sciences
High-potency Cannabis Impacts Memory, but not Decision-Making
JUL 08, 2021
High-potency Cannabis Impacts Memory, but not Decision-Making
High-potency cannabis products impair memory in various ways, according to new research published in Scientific Rep ...
JUL 15, 2021
Health & Medicine
The Effect of Cannabis Dispensary Density on Young People's Cannabis Use
JUL 15, 2021
The Effect of Cannabis Dispensary Density on Young People's Cannabis Use
As cannabis dispensaries have sprung up in legal states all around the USA, there has been little analysis of their impa ...
AUG 12, 2021
Cannabis Sciences
Medicinal Cannabis May Help with Stuttering
AUG 12, 2021
Medicinal Cannabis May Help with Stuttering
Medicinal cannabis reduced treatment-resistant stuttering in a 20-year-old male patient. The case study was published in ...
NOV 05, 2021
Cannabis Sciences
THC & ASD: A Crucial Contributor to Symptom Alleviation
NOV 05, 2021
THC & ASD: A Crucial Contributor to Symptom Alleviation
Up until recently, cannabis-based treatments for Autism Spectrum Disorder (ASD) have focused on CBD-enrichment and THC d ...
Loading Comments...